Excitatory Amino Acids in Neonatal Brain: Contributions to Pathology and Therapeutic Strategies

Overview

Journal Arch Dis Child Fetal Neonatal Ed

Specialties Gynecology & Obstetrics
Pediatrics

Date 1995 May 1

PMID 7796227

Citations 6

Authors

S W DSouza

P Slater

Affiliations

Soon will be listed here.

Citing Articles

Lentiviral expression of calpain-1 C2-like domain peptide prevents glutamate-induced cell death in mouse hippocampal neuronal HT22 cells.

Oikawa T, Fukuda T, Yamashita T, Tomita H, Ozaki T In Vitro Cell Dev Biol Anim. 2022; 58(4):289-294.

PMID: 35469046 DOI: 10.1007/s11626-022-00683-w.

Early Changes in Glutamate Metabolism and Perfusion in Basal Ganglia following Hypoxia-Ischemia in Neonatal Piglets: A Multi-Sequence 3.0T MR Study.

Dang Y, Shi K, Wang X Front Physiol. 2017; 8:237.

PMID: 28487658 PMC: 5404207. DOI: 10.3389/fphys.2017.00237.

Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.

Donovan M, Griffin B, Kharoshankaya L, Cryan J, Boylan G Drugs. 2016; 76(6):647-61.

PMID: 26943929 DOI: 10.1007/s40265-016-0554-7.

Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Donovan M, Boylan G, Murray D, Cryan J, Griffin B Br J Clin Pharmacol. 2015; 81(1):62-77.

PMID: 26302437 PMC: 4693568. DOI: 10.1111/bcp.12753.

Hypoxic-ischemic brain damage in perinatal age group.

Kumar K Indian J Pediatr. 2000; 66(4):475-82.

PMID: 10798099 DOI: 10.1007/BF02727151.

References

DSouza S, McConnell S, Slater P, BARSON A . Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain. Arch Dis Child. 1993; 69(2):212-5. PMC: 1029459. DOI: 10.1136/adc.69.2.212. View

Anis N, Berry S, Burton N, Lodge D . The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol. 1983; 79(2):565-75. PMC: 2044888. DOI: 10.1111/j.1476-5381.1983.tb11031.x. View

Seeburg P . The TiPS/TINS lecture: the molecular biology of mammalian glutamate receptor channels. Trends Pharmacol Sci. 1993; 14(8):297-303. DOI: 10.1016/0165-6147(93)90047-N. View

Rogawski M . Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci. 1993; 14(9):325-31. DOI: 10.1016/0165-6147(93)90005-5. View

Le BOURDELLES B, Wafford K, Kemp J, Marshall G, Bain C, Wilcox A . Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J Neurochem. 1994; 62(6):2091-8. DOI: 10.1046/j.1471-4159.1994.62062091.x. View

Greenamyre J, Olson J, Penney Jr J, Young A . Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. J Pharmacol Exp Ther. 1985; 233(1):254-63. View

Hagberg H, Lehmann A, Sandberg M, Nystrom B, Jacobson I, Hamberger A . Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab. 1985; 5(3):413-9. DOI: 10.1038/jcbfm.1985.56. View

Sandberg M, Butcher S, Hagberg H . Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem. 1986; 47(1):178-84. DOI: 10.1111/j.1471-4159.1986.tb02847.x. View

Wong E, Kemp J, Priestley T, Knight A, Woodruff G, Iversen L . The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986; 83(18):7104-8. PMC: 386661. DOI: 10.1073/pnas.83.18.7104. View

10.

Davies J, Evans R, Herrling P, Jones A, Olverman H, Pook P . CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res. 1986; 382(1):169-73. DOI: 10.1016/0006-8993(86)90127-7. View

11.

Pearce I, Burgoyne R . Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Lett. 1987; 223(1):143-7. DOI: 10.1016/0014-5793(87)80525-2. View

12.

Reynolds I, Miller R . Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol. 1988; 33(6):581-4. View

13.

Mattson M, Dou P, Kater S . Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J Neurosci. 1988; 8(6):2087-100. PMC: 6569320. View

14.

Kemp J, FOSTER A, Leeson P, Priestley T, Tridgett R, Iversen L . 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A. 1988; 85(17):6547-50. PMC: 282010. DOI: 10.1073/pnas.85.17.6547. View

15.

Monaghan D, Bridges R, Cotman C . The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989; 29:365-402. DOI: 10.1146/annurev.pa.29.040189.002053. View

16.

Clark G . Role of excitatory amino acids in brain injury caused by hypoxia-ischemia, status epilepticus, and hypoglycemia. Clin Perinatol. 1989; 16(2):459-74. View

17.

Singh L, Donald A, FOSTER A, Hutson P, Iversen L, Iversen S . Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proc Natl Acad Sci U S A. 1990; 87(1):347-51. PMC: 53260. DOI: 10.1073/pnas.87.1.347. View

18.

Choi D . Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988; 1(8):623-34. DOI: 10.1016/0896-6273(88)90162-6. View

19.

McDonald J, Johnston M . Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev. 1990; 15(1):41-70. DOI: 10.1016/0165-0173(90)90011-c. View

20.

HUTTENLOCHER P . Morphometric study of human cerebral cortex development. Neuropsychologia. 1990; 28(6):517-27. DOI: 10.1016/0028-3932(90)90031-i. View